Cargando…
Brain iron quantification by MRI in mitochondrial membrane protein-associated neurodegeneration under iron-chelating therapy
Therapeutic trials for Neurodegeneration with Brain Iron Accumulation have aimed at a reduction of cerebral iron content. A 13-year-old girl with mitochondrial membrane protein-associated neurodegeneration treated with an iron-chelating agent was monitored by R2 relaxometry, R2* relaxometry, and qua...
Autores principales: | Löbel, Ulrike, Schweser, Ferdinand, Nickel, Miriam, Deistung, Andreas, Grosse, Regine, Hagel, Christian, Fiehler, Jens, Schulz, Angela, Hartig, Monika, Reichenbach, Jürgen R, Kohlschütter, Alfried, Sedlacik, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284129/ https://www.ncbi.nlm.nih.gov/pubmed/25574478 http://dx.doi.org/10.1002/acn3.116 |
Ejemplares similares
-
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica – A Pilot Study
por: Doring, Thomas Martin, et al.
Publicado: (2016) -
Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study
por: Langkammer, Christian, et al.
Publicado: (2012) -
NCL Disorders: Frequent Causes of Childhood Dementia
por: SCHULZ, Angela, et al.
Publicado: (2013) -
Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022) -
Quantification of different iron forms in the aceruloplasminemia brain to explore iron-related neurodegeneration
por: Vroegindeweij, Lena H.P., et al.
Publicado: (2021)